Results 121 to 130 of about 149,839 (140)
Some of the next articles are maybe not open access.
Analysis of the tumor microenvironment using imaging mass cytometry data
The tumor microenvironment (TME) plays a pivotal role in tumor development, influencing interactions with immune cells, tumor progression, and responses to treatment. Understanding the heterogeneity of the TME is essential for uncovering the mechanisms underlying cell-to-cell interactions and their contribution to tumor dynamics. Recent advancements inZuzana, Loncova +2 more
openaire +2 more sources
Imaging Mass Cytometry to Decipher the Maturation of Tertiary Lymphoid Structures
In the realm of inflammation, including conditions like cancers, infections, and autoimmune diseases, the emergence of tertiary lymphoid structures (TLS) holds significant implications for prognosis and treatment response. Yet, traditional methodologies such as immunohistochemistry and immunofluorescence falter in capturing the nuanced complexities of ...Le Rochais, Marion +4 more
openaire +3 more sources
Advances in molecular biology are partially dependent on methodological innovation. Spatially resolved multi-omics, for example, promises to interrogate tissue architectures and mechanisms at unprecedented detail. However, these new experimental techniques introduce computational challenges in disentangling complex data into interpretable bits.
openaire +1 more source
openaire +1 more source
Insights into highly multiplexed tissue images: A primer for Mass Cytometry Imaging data analysis
TrAC - Trends in Analytical Chemistry, 2022Yaquan Liu
exaly
ImaCytE: Visual Exploration of Cellular Micro-Environments for Imaging Mass Cytometry Data
IEEE Transactions on Visualization and Computer Graphics, 2021Boudewijn Lelieveldt +2 more
exaly
A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry
Cell Metabolism, 2019Vito R T Zanotelli +2 more
exaly
Imaging mass cytometry in preclinical studies of lung cancer
Over the past 50 years, lung cancer has been responsible for the greatest number of cancer-related deaths worldwide. Despite improvements in cancer management and a large research effort toward developing targeted therapies, the 5-year survival rate after a lung cancer diagnosis is still only 23% (Quaresma et al., 2015; Siegel et al., 2023).openaire +2 more sources